Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline

BACKGROUND: The live attenuated 17DD Yellow Fever vaccine is one of the most successful prophylactic interventions for controlling disease expansion ever designed and utilized in larger scale. However, increase on worldwide vaccine demands and manufacturing restrictions urge for more detailed dose s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Infect Dis
Asıl Yazarlar: Campi-Azevedo, Ana Carolina, de Almeida Estevam, Paula, Coelho-dos-Reis, Jordana Grazziela, Peruhype-Magalhães, Vanessa, Villela-Rezende, Gabriela, Quaresma, Patrícia Flávia, Maia, Maria de Lourdes Sousa, Farias, Roberto Henrique Guedes, Camacho, Luiz Antonio Bastos, Freire, Marcos da Silva, Galler, Ricardo, Yamamura, Anna Maya Yoshida, Almeida, Luiz Fernando Carvalho, Lima, Sheila Maria Barbosa, Nogueira, Rita Maria Ribeiro, Silva Sá, Gloria Regina, Hokama, Darcy Akemi, de Carvalho, Ricardo, Freire, Ricardo Aguiar Villanova, Filho, Edson Pereira, Leal, Maria da Luz Fernandes, Homma, Akira, Teixeira-Carvalho, Andréa, Martins, Reinaldo Menezes, Martins-Filho, Olindo Assis
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4223624/
https://ncbi.nlm.nih.gov/pubmed/25022840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-391
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller